<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00004982</url>
  </required_header>
  <id_info>
    <org_study_id>CHELATION (completed)</org_study_id>
    <secondary_id>1R01DK055463-01</secondary_id>
    <nct_id>NCT00004982</nct_id>
    <nct_alias>NCT00004536</nct_alias>
  </id_info>
  <brief_title>Combination Iron Chelation Therapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</source>
  <brief_summary>
    <textblock>
      Patients with beta-thalassemia (Cooley's Anemia) continue to suffer from the&#xD;
      transfusion-induced iron overload due to the inadequacies of current iron-chelation therapy.&#xD;
      Compliance with the use of the only FDA-approved drug for removing excess iron from patients&#xD;
      (Desferal) continues to be a major problem despite convincing evidence that it markedly&#xD;
      reduces morbidity and prolongs life. The full potential of iron-chelation therapy will not be&#xD;
      realized until an orally-effective drug is available. This small trial is testing the premise&#xD;
      that a combination of drugs as a new approach to iron chelation therapy may reduce side&#xD;
      effects and increase efficacy. If both drugs can be given orally, there may be a better&#xD;
      chance of finding a suitable alternative to Desferal. Several combinations of experimental&#xD;
      iron chelating drugs are being used in this trial.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 1998</start_date>
  <completion_date>November 2002</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Iron Overload</condition>
  <condition>Thalassemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Combination Iron Chelation Therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Iron overload&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Overt cardiac disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cornell University Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <study_first_submitted>March 13, 2000</study_first_submitted>
  <study_first_submitted_qc>March 13, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2000</study_first_posted>
  <last_update_submitted>January 12, 2010</last_update_submitted>
  <last_update_submitted_qc>January 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2010</last_update_posted>
  <keyword>chelation therapy</keyword>
  <keyword>combination chemotherapy</keyword>
  <keyword>iron poisoning</keyword>
  <keyword>thalassemia</keyword>
  <keyword>chelating agent</keyword>
  <keyword>deferoxamine</keyword>
  <keyword>drug screening /evaluation</keyword>
  <keyword>therapy evaluation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>Iron Overload</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

